HighTower Advisors
COCH icon

HighTower Advisors’s Envoy Medical COCH Stock Holding History

HighTower Advisors’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-164,322
Closed -$388K – 3785
2024
Q2 		$388K Hold
164,322
– – ﹤0.01% 2507
2024
Q1 		$644K Buy
+164,322
New +$481K ﹤0.01% 2096

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

HighTower Advisors's COCH Position: Q3 2024 in Review

HighTower Advisors sold out of Envoy Medical (COCH) in Q3 2024, closing a stake of 164,322 shares — an estimated $388K sold.

HighTower Advisors first reported a position in COCH in Q1 2024 and held it in 2 quarters. The position peaked at $644K in Q1 2024. 18 funds tracked by Wall St. Rank hold COCH as of Q3 2024.

  • HighTower Advisors reported no remaining Envoy Medical position as of Q3 2024 after selling out during the quarter.
  • HighTower Advisors sold 164,322 Envoy Medical shares in Q3 2024, an estimated $388K.
  • HighTower Advisors first reported a position in Envoy Medical in Q1 2024 and held it in 2 quarters.
  • HighTower Advisors's Envoy Medical position peaked at $644K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2024.

Based on HighTower Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.